WINDSOR JAMES BRIAN bought RNTX
April 30, 2026 · Form 4 insider transaction
WINDSOR JAMES BRIAN bought 25,000 shares of Rein Therapeutics Inc. at $1.00 per share, a transaction worth $25.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 13 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$1.00
Total value
$25.0K
InsiderWINDSOR JAMES BRIAN
RoleOfficer, Director
SecurityCommon stock , $0.001 par value
Transaction codeP: Open-market purchase
Transaction dateApril 30, 2026
Filing dateMay 13, 2026
Shares owned after27,046
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares purchased in Issuer's April 30, 2026 follow-on public offering.